Keyphrases
Adult Patients
25%
Am(III)
25%
Arteriopathy
50%
Cardiac Transplantation
25%
Cellular Rejection
25%
Continuous Monitoring
25%
Cyclosporine
25%
Early Mortality
25%
Endomyocardial Biopsy
25%
Heart Transplant Recipients
25%
High Survival
25%
Hospitalization
50%
Hypertension
50%
Immunosuppressive Therapy
100%
Infant Patients
25%
Invasive Coronary Angiography
25%
Low Dose Rate
25%
Mean Group
25%
Nineteen
25%
Noninfectious Complications
25%
Older children
50%
Orthotopic Transplantation
25%
Pediatric Heart Transplant
100%
Postoperative Length of Stay
25%
Rejection Rate
25%
Serious Infection
50%
Survival Rate
25%
Survivors
25%
Transplantation
75%
Medicine and Dentistry
Adolescence
25%
Antihypertensive
25%
Artery Disease
50%
Azathioprine
25%
Cellular Rejection
25%
Coronary Angiography
25%
Cyclosporine
25%
Heart Graft
25%
Heart Muscle Biopsy
25%
Heart Transplantation
100%
Immunosuppressive Treatment
100%
Infection
100%
Orthotopic Transplantation
25%
Pediatrics
100%
Prevalence
25%
Steroid Therapy
25%
Survival Rate
25%